TP53 and neoplasm: Although no targeted therapy is currently available for TP53 mutated tumours, this topic is the subject of research, which focuses on small molecular compounds, synthetic small peptides, CRISPR/Cas9 mediated genome editing, or small interference RNAs (RNAi) [88].